EZ CONTROL, ATTAIN GOAL
Prevalence in Dyslipidemia
A MAJOR CLINICAL CHALLENGE
“The Rule of Six” Limitations
-6% LDL-C
-6% LDL-C
-6% LDL-C
Rosuvastatin + Ezetimibe 10mg

ADDITIONAL REDUCTION IN LDL-C
(Rosuvastatin + Ezetimibe)
Superior Potency.
Clinical Ease.
